Literature DB >> 31895605

Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in the First-Line Setting?

Tomohiro Tanaka1, Hiroto Ishiki1, Emi Kubo1, Sayuri Yokota1, Masaki Shimizu1, Daisuke Kiuchi1, Eriko Satomi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31895605     DOI: 10.1200/JCO.19.02509

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Case Report: Combined Small Cell Lung Carcinoma With Pulmonary Adenocarcinoma.

Authors:  Cheng Shen; Guowei Che
Journal:  Front Surg       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.